Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.bbi.2020.04.046 http://scihub22266oqcxt.onion/10.1016/j.bbi.2020.04.046 32334062!7175848!32334062     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32334062.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Brain+Behav+Immun 2020 ; 87 (ä): 59-73 Nephropedia Template TP {{tp|p=32334062|t=2020. Current status of potential therapeutic candidates for the COVID-19 crisis |pdf=|usr=}}{{32334062}} gab.com Text Current status of potential therapeutic candidates for the COVID-19 crisis JO: Brain Behav Immun http://www.kidney.de/pget.php?&tw=1&pmid=32334062 #FOAvip As of April 15, 2020, the ongoing coronavirus disease 2019 (COVID-2019) pandemic has swept through 213 countries and infected more than 1,870,000 individuals, posing an unprecedented threat to international health and the economy. There is currently no specific treatment available for patients with COVID-19 infection. The lessons learned from past management of respiratory viral infections have provided insights into treating COVID-19. Numerous potential therapies, including supportive intervention, immunomodulatory agents, antiviral therapy, and convalescent plasma transfusion, have been tentatively applied in clinical settings. A number of these therapies have provided substantially curative benefits in treating patients with COVID-19 infection. Furthermore, intensive research and clinical trials are underway to assess the efficacy of existing drugs and identify potential therapeutic targets to develop new drugs for treating COVID-19. Herein, we summarize the current potential therapeutic approaches for diseases related to COVID-19 infection and introduce their mechanisms of action, safety, and effectiveness. Twit Text FOAVip Current status of potential therapeutic candidates for the COVID-19 crisis ????Brain Behav Immun http://www.kidney.de/pget.php?&tw=1&pmid=32334062 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32334062 #FOAvip English Wikipedia <ref>{{Cite pmid|32334062}}</ref> Current status of potential therapeutic candidates for the COVID-19 crisis #MMPMID32334062 Zhang J; Xie B; Hashimoto K Brain Behav Immun 2020[Jul]; 87 (ä): 59-73 PMID32334062show ga As of April 15, 2020, the ongoing coronavirus disease 2019 (COVID-2019) pandemic has swept through 213 countries and infected more than 1,870,000 individuals, posing an unprecedented threat to international health and the economy. There is currently no specific treatment available for patients with COVID-19 infection. The lessons learned from past management of respiratory viral infections have provided insights into treating COVID-19. Numerous potential therapies, including supportive intervention, immunomodulatory agents, antiviral therapy, and convalescent plasma transfusion, have been tentatively applied in clinical settings. A number of these therapies have provided substantially curative benefits in treating patients with COVID-19 infection. Furthermore, intensive research and clinical trials are underway to assess the efficacy of existing drugs and identify potential therapeutic targets to develop new drugs for treating COVID-19. Herein, we summarize the current potential therapeutic approaches for diseases related to COVID-19 infection and introduce their mechanisms of action, safety, and effectiveness. |Adrenal Cortex Hormones/therapeutic use[MESH] |Angiotensin-Converting Enzyme 2[MESH] |Anti-Inflammatory Agents, Non-Steroidal/therapeutic use[MESH] |Antibodies, Monoclonal, Humanized/therapeutic use[MESH] |Anticoagulants/therapeutic use[MESH] |Antimalarials/therapeutic use[MESH] |Antiviral Agents/therapeutic use[MESH] |Betacoronavirus[MESH] |Bevacizumab/therapeutic use[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |COVID-19 Serotherapy[MESH] |COVID-19 Vaccines[MESH] |Chloroquine/therapeutic use[MESH] |Coronavirus Infections/drug therapy/prevention & control/*therapy[MESH] |Humans[MESH] |Hydroxychloroquine/therapeutic use[MESH] |Immunization, Passive[MESH] |Immunoglobulins, Intravenous/therapeutic use[MESH] |Immunologic Factors/therapeutic use[MESH] |Interferons/therapeutic use[MESH] |Janus Kinase Inhibitors/therapeutic use[MESH] |Killer Cells, Natural[MESH] |Medicine, Chinese Traditional[MESH] |Mesenchymal Stem Cell Transplantation[MESH] |Nitric Oxide/therapeutic use[MESH] |Pandemics[MESH] |Peptidyl-Dipeptidase A[MESH] |Pneumonia, Viral/*therapy[MESH] |SARS-CoV-2[MESH] |Spike Glycoprotein, Coronavirus[MESH] |Trace Elements/therapeutic use[MESH] |Viral Vaccines/therapeutic use[MESH] |Vitamins/therapeutic use[MESH]Current status of potential therapeutic candidates for the COVID-19 cr(epmc).pdf DeepDyve Pubget Overpricing